메뉴 건너뛰기
Future Microbiology
Volumn 6, Issue 6, 2011, Pages 601-602
Antimicrobial drug discovery
Author keywords

[No Author keywords available]
Indexed keywords

5 FLUORO 1,3 DIHYDRO 2,1 BENZOXABOROL 1 OL; ANTIMALARIAL AGENT; CARBAPENEM; FEXINIDAZOLE;
EID: 79959772455     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.54     Document Type: Editorial
Times cited : (2)
References (10)
  • 1
    • 79959778616 scopus 로고    scopus 로고
    • Are nonlethal targets useful for developing novel antimicrobials
    • Martínez JL, Rojo F, Vila J: Are nonlethal targets useful for developing novel antimicrobials? Future Microbiol. 6(6), 605-607 (2011
    • (2011) Future Microbiol. , vol.6 , Issue.6 , pp. 605-607
    • Martínez, J.L.1    Rojo, F.2    Vila, J.3
  • 2
    • 79959781700 scopus 로고    scopus 로고
    • How antibacterials really work: Impact on drug discovery
    • Dick T, Young D: How antibacterials really work: impact on drug discovery. Future Microbiol. 6(6), 603-604 (2011
    • (2011) Future Microbiol. , vol.6 , Issue.6 , pp. 603-604
    • Dick, T.1    Young, D.2
  • 3
    • 79959792864 scopus 로고    scopus 로고
    • Relationship between pharmacodynamic indices and killing patterns in vitro
    • Mouton JW: Relationship between pharmacodynamic indices and killing patterns in vitro. Future Microbiol. 6(6), 613-616 (2011
    • (2011) Future Microbiol. , vol.6 , Issue.6 , pp. 613-616
    • Mouton, J.W.1
  • 4
    • 79551572096 scopus 로고    scopus 로고
    • A novel approach to pharmacodynamic assessment of antimicrobial agents: New insights to dosing regimen design
    • Tam VH, Nikolaou M: A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design. PLoS Comput. Biol. 7(1), E1001043 (2011
    • (2011) PLoS Comput. Biol. , vol.7 , Issue.1
    • Tam, V.H.1    Nikolaou, M.2
  • 5
    • 79959794071 scopus 로고    scopus 로고
    • Tuberculosis drugs: New candidates and how to find more
    • Sala C, Hartkoorn RC: Tuberculosis drugs: new candidates and how to find more. Future Microbiol. 6(6), 617-633 (2011
    • (2011) Future Microbiol. , vol.6 , Issue.6 , pp. 617-633
    • Sala, C.1    Hartkoorn, R.C.2
  • 6
    • 79959790048 scopus 로고    scopus 로고
    • Road to clinical efficacy: Challenges and novel strategies for antimicrobial peptide development
    • Eckert R: Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol. 6(6), 635-651 (2011
    • (2011) Future Microbiol. , vol.6 , Issue.6 , pp. 635-651
    • Eckert, R.1
  • 7
    • 79959776949 scopus 로고    scopus 로고
    • Antimicrobials for bacterial bioterrorism agents
    • Sarkar-Tyson M, Atkins HS: Antimicrobials for bacterial bioterrorism agents. Future Microbiol. 6(6), 667-676 (2011
    • (2011) Future Microbiol. , vol.6 , Issue.6 , pp. 667-676
    • Sarkar-Tyson, M.1    Atkins, H.S.2
  • 8
    • 79959803273 scopus 로고    scopus 로고
    • Therapeutic options for infections with enterobacteriaceae producing carbapenem-hydrolyzing enzymes
    • Falagas ME, Karageorgopoulos DE, Nordmann P: Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol. 6(6), 653-666 (2011
    • (2011) Future Microbiol. , vol.6 , Issue.6 , pp. 653-666
    • Falagas, M.E.1    Karageorgopoulos, D.E.2    Nordmann, P.3
  • 9
    • 79959773283 scopus 로고    scopus 로고
    • Target identification and validation of novel antimalarials
    • McNamara C, Winzeler EA: Target identification and validation of novel antimalarials. Future Microbiol. 6(6), 693-704 (2011
    • (2011) Future Microbiol. , vol.6 , Issue.6 , pp. 693-704
    • McNamara, C.1    Winzeler, E.A.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.